Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis

Clinical trial NCT04854096 · TERMINATED

Trial details

NCT number: NCT04854096
Sponsor: NS Pharma, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Myelofibrosis Post-essential Thrombocythemia Myelofibrosis Post-polycythemia Vera Myelofibrosis

Start date: 2023-01-31
Primary completion: 2024-05-16
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.